Changchun Wen

Changchun Wen

Auto-generated profile, based on publicly available information

Changchun Wen

Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, University Engineering Research Center for Chemistry of Characteristic Medicinal Resources (Guangxi), School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2023 in ACS Nano
Verified
Journal Article
Closed access
PXPeijing Xu
Peijing Xu
CWChangchun Wen
Changchun Wen
CGCunji Gao
Cunji Gao
HLHuihui Liu
Huihui Liu
YLYingshu Li
Yingshu Li
HLHong Liang
Hong Liang

11 May 2022 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
CWChangchun Wen
Changchun Wen
XGXiaolu Guo
Xiaolu Guo
CGCunji Gao
Cunji Gao
ZZZhongkai Zhu
Zhongkai Zhu
NMNianqi Meng
Nianqi Meng
HLHong Liang
Hong Liang
A NIR-II responsive AuNRs@SiO2–RB@MnO2nanotheranostic has been successfully fabricated for photoacoustic and multimodal imaging-guided chemodynamic/photothermal synergistic therapies for tumors.


28 September 2024 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
NLNan Leng
Nan Leng
YZYuzhu Zhou
Yuzhu Zhou
CWChangchun Wen
Changchun Wen
QFQi Fang
Qi Fang
XGXiaohuan Guo
Xiaohuan Guo
HLHong Liang
Hong Liang

6 June 2025 in Materials Today Bio
Verified
Journal Article
Open access
XGXiaohuan Guo
Xiaohuan Guo
BCBingbing Cai
Bingbing Cai
QFQi Fang
Qi Fang
YCYanyan Chen
Yanyan Chen
YZYuzhu Zhou
Yuzhu Zhou
HLHong Liang
Hong Liang
The high level of glutathione (GSH) in tumor cells can consume reactive oxygen species (ROS), seriously affecting the efficacy of chemodynamic therapy (CDT). Although it took a great deal of effort, developing a tumor-specific CDT that efficiently depletes GSH remains a formidable challenge. Herein, we propose a pH-responsive nanocatalyst containing the active molecule norcantharidin (NCTD) and Cu2+ for dual GSH depletion, achieving efficient GSH depletion. Due to the weakly acidic tumor microenvironment (TME), the catalyst releases NCTD and Cu2+ in a pH-responsive manner for the synergistic therapy of chemotherapy (CT) and CDT. Both components consume GSH and subsequently produce ROS, reducing the antioxidant capacity of cancer cells while increasing oxidative stress. This disrupts cellular redox homeostasis, leading to mitochondrial dysfunction and inducing tumor cell apoptosis. This work not only develops nanomaterials with dual GSH depletion capabilities for high-efficiency CDT but also achieves synergistic CT and CDT tumor therapy with the addition of NCTD, an active ingredient of traditional Chinese medicine.

15 September 2023 in Biomedical Materials
Verified
Journal Article
Closed access
JZJing Zhang
Jing Zhang
MHMiaomiao Hu
Miaomiao Hu
CWChangchun Wen
Changchun Wen
JLJian Liu
Jian Liu
FYFang Yu
Fang Yu
XLXiangcheng Lin
Xiangcheng Lin
Single tumor treatment method usually has some defects, which makes it difficult to achieve good therapeutic effect. The ingenious combination of multiple tumor treatment methods on a single nanoplatform to achieve multifunctional treatment can effectively improve the efficiency of treatment. The targeted modification of nanomaterials can augment the precision of nanotherapeutic drugs in tumor treatment. Herein, a multifunctional nanoplatform (CeO2@CuS@PDA-FA) based on cerium dioxide nanoparticles engineered with copper sulfide (CeO2@CuS) has been constructed for synergistic photothermal therapy (PTT) and chemodynamic therapy (CDT). The CeO2@CuS were coated using polydopamine (PDA), and the modification of PDA surface by folic acid, in order to achieve the targeted effect for tumors. The localized hyperthermia induced by PTT can further improve the CDT efficiency of the nanoplatform, leading to a PTT/CDT synergistic effect. The nanoplatform possessed the capability of cancer cell-targeted and achieved better therapeutic efficacy in vitro. This work provided a new strategy for combined multifunctional theranostic platform and shows strong potential in practical applications.